| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dexamethasone acetate |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone measurement |
Component |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone adverse reaction |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Topical dexamethasone adverse reaction |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| bivirkning af kombinationspræparat med dexamethason til topikal anvendelse |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dexamethasone |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| allergi over for dexamethason til topikal anvendelse |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| allergi over for dexamethasonkombinationspræparat til topikal anvendelse |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone overdose |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Accidental dexamethasone overdose |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Intentional dexamethasone overdose |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| overdosis af dexamethason, uvist med hvilken hensigt |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 100 microgram/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 2 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 2 mg/5 ml flydende |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| dexamethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 10 mg/25 g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,5 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,1 % wt/vol + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 1 mg + neomycinsulfat 3,5 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 1 mg + tobramycin 3 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethasonnatriumphosphat 24 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethasonnatriumphosphat 4 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethasonnatriumphosphat 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone ophthalmic preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone nasal preparation |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Desoximetasone (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone phosphate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| dexamethason-21-isonicotinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,1 % + hypromellose 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| kombinationspræparat med dexamethason til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone compound eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| dexamethasonnatriumphosphat 1 mg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethasonnatriumphosphat 0,1 mg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| dexamethason + neomycinsulfat + polymyxin B-sulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Tramazoline hydrochloride+dexamethasone isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing ciprofloxacin and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| ciprofloxacin 0,3 % + dexamethason 0,1 % steril suspension til anvendelse i øre |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Product containing dexamethasone and tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing dexamethasone in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 700 microgram prolonged-release ocular implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| allergi over for dexamethasonkombinationspræparat til topikal anvendelse |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dexamethasone |
Causative agent |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| allergi over for dexamethason til topikal anvendelse |
Causative agent |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone sodium metasulfobenzoate (substance) |
Is a |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium metasulfobenzoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone sodium phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 6 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone 750 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
| Dexamethasone isonicotinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
|
| Dexamethasone 100 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone (substance) |
Inferred relationship |
Some |
1 |
FHIR